Fineline Cube

Follow:
14778 Articles
CompanyDrug

JW Therapeutics’ CAR-T Therapy Carteyva Secures NMPA Approval for Mantle Cell Lymphoma Indication

CompanyDrug

Shanghai-Based ANEXT Commences Clinical Trials for Exosome Product ANEXT FIT CELL in Respiratory Conditions

Company

Shanghai Fosun Pharmaceutical Reports 5.31% YOY Revenue Growth and Strong R&D Investment in 2024H1 Report

CompanyDeals

Shanghai BDgene Partners with SPH RD to Develop Hemophilia Treatments Using BDlendi Insulator Technology

CompanyDrug

Legend Biotech’s Carvykti Receives NMPA Approval for Relapsed/Refractory Multiple Myeloma After Multi-Center Phase II Study

CompanyDrug

Jiangsu Hengrui’s Vunakizumab Receives NMPA Approval as First Homegrown Autoimmune IL-17A Drug

Company

Luye Pharma’s Subsidiary Boan Bio Reports 2024H1 Revenue Growth and First Full Year of Profitability

CompanyDrug

Hinova Pharmaceuticals’ HP515 Receives NMPA Approval for NASH Clinical Study

Company

Walvax Biotechnology Reports 2024H1 Revenue Dip Amid Intense Vaccine Market Competition

CompanyDrug

Bio-Thera Solutions’ BAT8006 Receives NMPA Approval for Clinical Trial in Recurrent Ovarian Cancer Maintenance Therapy

CompanyDrug

Chongqing Genrix Biopharmaceutical Receives NMPA Approval for Xeligekimab, First Domestic Anti-IL-17 Antibody

Legal / IP

Takeda’s Entyvio Receives Historic Patent Term Adjustment in China, a First for the Country